- 01 Batch review from 20 days to 1 day (Valent BioSciences)
- 02 2,700 person-hours saved annually on review and documentation
- 03 Review-by-exception — QA focuses on the 5% that needs judgement
- 04 60% reduction in manual data entries via instrument integration
What FDA Inspectors Cite
Batch review and release failures are among the most frequently cited 483 observations. These findings reveal what happens when review processes cannot keep pace with production.
Production revised batch records without Quality Unit knowledge
Baxter Oncology GmbH
September 26, 2025
The batch record was revised repeatedly by Production to fix missing times and signatures — without QA knowledge or approval. Correction forms were found in the Supervisor's office and discard bins. The Quality Unit lacked visibility to detect these changes.
Why Batch Review Takes Weeks Instead of Hours
The review bottleneck is not about reviewer capability — it is about process design. Paper and legacy-digital systems force QA into a line-by-line model that cannot scale.
Challenge 1/6
Line-by-Line Review of 200–500 Pages
- 01Reviewers spend equal time on routine within-spec entries and genuine exceptions
- 02A single missed signature or unchecked field triggers investigation and batch hold
- 03No mechanism distinguishes verified-at-source data from manually transcribed entries
Agentic Architecture
Four specialized AI agents orchestrated by Leucine MES, each with domain-specific skills, transforming batch review from manual page-turning to intelligent exception management.
Data Layer
Leucine MES
Orchestration Layer
Orchestrates review workflows, manages reviewer assignments, enforces 21 CFR Part 11 compliance across every action
Quality Outputs
Batch Review in Leucine MES
1.AI Pre-Review — Cortex Scans Before You Do
Before a human reviewer opens the record, Cortex AI has already verified every CPP against specification, confirmed material reconciliation, and flagged deviations. The reviewer inherits a pre-reviewed record, not a blank document.
2.Review-by-Exception — Focus on the 5% That Matters
The reviewer sees a focused exception report: out-of-spec parameters, unresolved deviations, missing verifications. Compliant steps are acknowledged efficiently. QA time goes to judgement calls, not routine confirmation.
3.Automated Deviation Linkage
Every deviation detected during production is automatically linked to the batch record with its investigation status and CAPA reference. The reviewer sees: deviation → root cause → CAPA → resolution in one view.
4.Parallel Review Workflows
Multiple reviewers — production supervisor, QA reviewer, QP — review simultaneously instead of sequentially. Digital routing eliminates physical handoff. All comments and decisions converge in one audit trail.
5.One-Click Release Dashboard
The QP sees a release dashboard: all CPPs verified ✓, all deviations resolved ✓, all materials reconciled ✓. One electronic signature to release the batch — with a complete audit trail backing every checkmark.
Inputs
Cortex Compliance Agent
LeucineOS Agent
Outputs
Inputs
Review Engine
LeucineOS Agent
Outputs
Inputs
Deviation Intelligence
LeucineOS Agent
Outputs
Inputs
Workflow Orchestrator
LeucineOS Agent
Outputs
Inputs
Release Engine
LeucineOS Agent
Outputs
How Leucine Solves This
Addressing both the review bottleneck that holds product in quarantine and the compliance gaps that FDA finds in batch disposition processes.
Batch Release in Hours, Not Weeks
Cortex AI pre-reviews the complete batch record. QA reviewers engage only with flagged exceptions. The Quality Unit maintains full oversight with a sealed audit trail.
Capabilities
- AI pre-review verifying every CPP, material reconciliation, and equipment status
- Exception-based review surfacing only items requiring human judgement
- Automated deviation linkage with investigation and CAPA status
- One-click release dashboard with completeness verification
Measurable Impact
Real results from manufacturers who replaced manual batch review with AI-powered review-by-exception.
Batch Review Time
Reduction in batch review cycle — from 20 days to 1 day at Valent BioSciences
Hours Recovered Annually
Person-hours saved per year on review and documentation at a single facility
Manual Data Entries
Fewer manual entries through direct instrument integration — fewer errors to review
Facilities Live
Manufacturing facilities using Leucine MES review-by-exception across FDA, EMA, and MHRA jurisdictions
Frequently asked questions
How does Cortex pre-review a batch record before a human opens it?
Cortex verifies every critical process parameter against specification, confirms material reconciliation, checks equipment status, and flags deviations, all before a reviewer opens the record. The reviewer inherits a pre-reviewed record and a focused exception summary, not a blank 200-page document. Agents advise; the release decision stays with your qualified person.
Does review by exception speed up release without weakening Quality Unit oversight?
Oversight increases. The Quality Unit sees every deviation linked to its investigation and CAPA status in one view, with a sealed audit trail behind every checkmark, instead of hunting across systems. Reviewers spend their time on judgement calls rather than confirming routine within-spec entries.
How are deviations and CAPA linked to the batch record?
Every deviation detected during execution is automatically linked to the batch record with its investigation status and CAPA reference. The reviewer follows deviation to root cause to CAPA to resolution in a single view, so missing or incomplete deviation linkage, a top FDA finding, cannot pass unseen.
Can multiple reviewers work the same batch record at once?
Yes. Production supervisor, QA reviewer, and qualified person review in parallel rather than passing a physical record from desk to desk. Digital routing removes the sequential handoffs that add days, and all comments and decisions converge in one audit trail.
What measurable change in review cycle time should we expect?
Valent BioSciences cut batch review from 20 days to 1 day and recovered 2,700 person-hours a year. Results scale with how much of the record is captured at source during execution, since records built right the first time are the records that review fastest.
Continue exploring
Powered by
Leucine MES
The Manufacturing Execution System for pharmaceutical manufacturing — from digitising batch records with full 21 CFR Part 11 compliance to connecting shop-floor data across a global facility network.
Explore Leucine MESStop losing weeks to batch review backlogs. Leucine MES pre-reviews every record with AI, surfaces only what needs your judgement, and releases batches the same day.